Trade Summary

4 days ago, Saxonov Serge, serving as CEO at 10X Genomics, Inc. (TXG), sold 9,632 shares at $18.58 per share, for a total transaction value of $178,928.00. Following this transaction, Saxonov Serge now holds 1,333,201 shares of TXG.

This sale represents a 1.00% decrease in Saxonov Serge's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

10X Genomics, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.